Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study
Listen to this summary
This study aimed to compare the oncologic and perioperative outcomes of minimally invasive radical hysterectomy (MIS-RH) without a uterine manipulator to open radical hysterectomy (O-RH) in patients with early-stage cervical cancer. The results indicated no significant differences in disease-free survival or overall survival between the two surgical approaches, though MIS-RH demonstrated several advantages in perioperative metrics such as reduced blood loss and shorter hospitalization. However, the authors caution that the shorter follow-up period and limited mortality data necessitate further investigation to confirm these findings.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Gynecologic oncology
View all →Sep 22, 2026 · Gynecologic oncology
Association of community-level social vulnerability with county-level clinical trial access among ovarian cancer patients
Sep 21, 2026 · Gynecologic oncology
Contemporary surgical management of vulvar cancer is associated with improved survival but increased reoperation rate: A Finnish nationwide study
Sep 21, 2026 · Gynecologic oncology
A phase II study in newly diagnosed stage III/IV epithelial ovarian cancer evaluating carboplatin/taxol/pembrolizumab in patients receiving neoadjuvant chemotherapy followed by pembrolizumab maintenance with or without olaparib
Sep 21, 2026 · Gynecologic oncology
Feasibility of real-time near-infrared fluorescence tracer imaging in sentinel lymph node biopsy for vulvar cancer patients
Sep 21, 2026 · Gynecologic oncology
Impact of palliative radiotherapy in patients with gynecologic malignancies on end-of-life outcomes
Sep 16, 2026 · Gynecologic oncology
Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201
More in Obstetrics & Gynecology
View all →Sep 23, 2026 · Gynecologic oncology reports
Fertility-sparing surgery for a patient with a pre-operative suspected diagnosis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A case report
Sep 23, 2026 · Gynecologic oncology reports
Abscopal effect following palliative radiotherapy after cemiplimab in recurrent cervical cancer: a case report
Sep 23, 2026 · International urogynecology journal
Comparison of Postoperative Functional Recovery and Anatomical Restoration in Patients with Pelvic Organ Prolapse Undergoing Three Types of Apical Suspension Techniques: A Retrospective Study
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · Human reproduction (Oxford, England)
Maternal TRIM28 safeguards bovine embryonic genome activation by regulating SAM-dependent methylation via lipid metabolism
Sep 23, 2026 · Gynecologic oncology reports
Trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian carcinoma after poly-ADP-ribose polymerase inhibitors progression: A real-world single-center experience
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


